). The changing spectrum of bacteria and antibiotic sus-P ! .00001 ceptibility patterns in HIV-1-infected children requires a reevaluation of the empirical treatment of community-acquired severe LRTI in children from developing countries with a high prevalence of childhood HIV-1 infection.
Increased Disease Burden and Antibiotic Resistance of Bacteria Causing Severe Community-Acquired Lower Respiratory Tract Infections in Human Immunodeficiency Virus Type 1-Infected Children
HIV-1 [4] . The prevalence of HIV-1 in mothers attending antenatal clinics in Soweto, South Africa, increased from 0.4% in 1990 to 22% in 1998 [5, 6] . Mother-to-child HIV-1 transmission studies suggest that ∼5% of children born during 1996-1997 at Chris Hani-Baragwanath Hospital, which serves the population of Soweto, were HIV-1 infected [7] . None of these children received antiretroviral therapy.
The same countries where the HIV epidemic remains entrenched contribute most to the childhood mortality from LRTI [1, 4] . The dominance of LRTI as the most common cause of hospitalization and mortality in HIV-1-infected and HIV-1-uninfected children at our site has been described elsewhere [8] . The increased predisposition of HIV-1-infected children to invasive bacterial diseases has also been described elsewhere [9] ; however, there are few studies detailing the differences in the burden of illness and antibiotic susceptibility patterns of bacteria in HIV-1-infected and HIV-1-uninfected children with community-acquired LRTI [3] . If differences were found in the spectrum of bacteria and antibiotic susceptibility of these isolates between HIV-1-infected and HIV-1-uninfected children with community-acquired severe LRTI, it would have impor-tant implications regarding the empirical choice of antibiotics in the management of these children in areas with a high prevalence of HIV infection.
This report describes our findings on the bacterial etiology, the drug susceptibility of the bacterial isolates, the clinical course of disease, and the in-hospital case-fatality rate (CFR) for severe LRTI in HIV-1-infected and HIV-1-uninfected children.
Patients and Methods

Patients.
A prospective study was conducted at Chris Hani-Baragwanath Hospital, Soweto, from March 1997 through February 1998. The hospital provides secondary and tertiary care to 1.2 million black urban South Africans, including ∼120,000 children aged !5 years [10] . We enrolled children aged 2-60 months who required hospitalization for severe LRTI. All children fulfilled the World Health Organization criteria for severe acute LRTI [11] and/or had an oxygen saturation of !90% in room air, as measured by pulse oximetry (3800 Pulse Oximeter; Ohmeda, Louisville, CO). To exclude nosocomial-acquired infections, children admitted within 14 days of a previous hospitalization were excluded from the analysis.
HIV-1 testing. Children were screened for HIV-1 antibodies using a third-generation HIV-1 ELISA test (Axsym system, HIV1/ 2; Abbot, Wiesbaden-Delkenheim, Germany). Positive results were confirmed with a different HIV-1 ELISA test (Murex HIV1ϩ2; Murex Diagnostics, Dartford, UK). HIV-1-seropositive children were categorized based on the revised clinical criteria of the Centers for Disease Control and Prevention (CDC) for HIV-1-infected children aged !13 years [12] . The HIV-1 status of children aged !15 months who had antibodies based on ELISA but who had !3 signs of acquired immunodeficiency syndrome (CDC AIDS category N and A, respectively) was confirmed by HIV-1 DNA PCR (Amplicor HIV-1 test; Roche Diagnostics, Nutley, NJ). Children in the above 2 AIDS categories were considered to be of indeterminate HIV-1 status if they did not have a HIV-1 PCR test performed or if they were HIV-1 PCR-negative with features that suggested CDC clinical category A for AIDS [12] .
Bacterial cultures. Blood was taken for culture on admission and processed using the BacT/Alert microbial detection system (Organon Teknika, Durham, NC). Pneumococcal and Haemophilus influenzae type b latex agglutination tests (Wellcogen Bacterial Antigen Kit: Murex Diagnostics) were performed on specimens that tested positive by the BacT/Alert method and were gram-positive but on which no further growth was detected. Antimicrobial susceptibility was performed using the disc diffusion method and interpreted using the 1997 National Committee for Clinical Laboratory Standards criteria for disc susceptibility testing [13] . MIC for antibiotics were determined by microdilution susceptibility testing for isolates of Streptococcus pneumoniae that were resistant by the disc method. National Committee for Clinical Laboratory Standards criteria were used to define antibiotic susceptibility [14] . Where available, MIC were used in preference to results obtained by the disc method. Isolation of bacteria of doubtful pathogenicity were considered to be contaminants and were not regarded as true bacteremic episodes.
Mycobacterium tuberculosis (MTB) infection. Investigation for MTB was performed at the discretion of the attending physicians. Because of the high prevalence of tuberculosis in South Africa, clinical investigations for tuberculosis were done frequently on children admitted for LRTI. Eight hundred and fifty-eight children (73.6%) had gastric washings sent for culture of MTB. MTB was isolated by using the Bactec 460TB7 system (Johnston Laboratories, Cockeysville, MD) and by plating onto Lowenstein-Jensen medium. To confirm MTB on growth detected by the Bactec system, PCR was performed using the insertion sequence IS 6110 as a probe.
Nutritional categorization. The nutritional categorization of children was based on the Wellcome classification for nutrition [15] .
Pneumocystis carinii pneumonia (PCP) infection. A clinical diagnosis of PCP was made if у3 of the following clinical criteria were present: clinical impression of dyspnea, severe hypoxia (cyanosis or oxygen saturation !86%, as measured by pulse oximetry), a lactate dehydrogenase level of 1000 U/L, and extensive infiltrate on chest radiograph.
Statistical analysis. Statistical analysis was performed using Epi Info version 6.04 (CDC, Atlanta, GA) and SAS software (SAS Institute, Cary, NC). Continuous and categorical variables were analyzed using unpaired Student's t tests and Mantel-Haenszel x 2 tests, respectively. Fisher's exact test was used when a cell had an expected value of !5 observations. Medians (25th-75th percentile) were used for all age-related analyses, and the mean and SD were calculated for continuous variables. RR and 95% CI were used in describing risk differences between HIV-1-infected and HIV-1-uninfected children.
was considered statistically significant. P ! .05 Incidence figures and RR for children aged 2-23 months were estimated based on the assumption that the birth cohort for the study area was 24,000 per annum (statistics of the Department of Obstetrics, Chris Hani-Baragwanath Hospital) and that 5% of all children born in Soweto are HIV-1-infected. To assess the independence of risk factors for bacteremia and mortality, adjusted OR (AOR) were calculated using logistic regression analysis.
Results
Of the 1434 children enrolled, 70 did not have any blood culture performed and 149 were admitted within 14 days of a previous hospitalization. These children were excluded from our analyses. Of the remaining 1215 children, 548 (45.1%) were HIV-1-infected and 617 (50.8%) were HIV-1-uninfected. The HIV-1 status was indeterminate in 50 children (4.1%), including 2 who were never tested. Overall, 700 children (57.6%) were male. HIV-1-infected children were older and more likely to be malnourished than HIV-1-uninfected children (RR, 1.9; 95% CI, 1.64-2.21; table 1).
HIV-1 categorization.
Of the HIV-1-infected children, 6.5% were categorized clinically as asymptomatic, 13.7% as mildly symptomatic, 55.1% as moderately symptomatic, and 24.7% as severely symptomatic. Of the 384 HIV-1-infected children aged !15 months, HIV-1 status was confirmed by HIV-1 PCR in 26 asymptomatic and 25 mildly symptomatic children. ). In 6 children with gram-P ! .00001 positive diplococci and 2 with gram-negative bacilli, initial growth was detected by the BactT/Alert method, and the broth latex-agglutination test was positive for either S. pneumoniae or H. influenzae type b, respectively, but no further growth of the organism was obtained. These children were classified as having bacteremia. HIV-1-infected children with bacteremia were older than uninfected children (table 1) . The bacteria cultured from blood are shown in table 3.
The overall estimated burden of disease for each of the clinically significant pathogens in children aged !2 years was greater in HIV-infected than in HIV-1-uninfected children ( ). A history of using antibiotics at the time of P p .005 blood culture did not correlate with a lower rate of bacterial isolation among children with severe LRTI.
Antibiotic resistance. Table 5 shows the susceptibility patterns of the 4 most common isolates to antibiotics commonly used in the empirical treatment of community-acquired LRTI in children. High-level penicillin resistance (MIC, 2 mg/mL) was present in 6 (16.2%) of 37 HIV-1-infected children and 1 (7.8%) of 13 HIV-1-uninfected children with pneumococcal bacteremia ( ) . P p .65
Methicillin resistant S. aureus (MRSA) was more common in HIV-1-infected than HIV-1-uninfected children (6 [60%] of 10 versus 0 [0%] of 4), although this difference was not statistically significant ( ). In HIV-1-infected children, 85.7% P p .08 of the E. coli isolates were simultaneously resistant to both ampicillin and trimethoprim-sulfamethoxazole (TMP-SMZ).
MTB infection. HIV-1-infected children were more likely to be investigated for MTB than were HIV-1-uninfected children (77% vs. 70%, respectively;
). MTB was isolated P p .008 from 36 (8.5%) of 423 HIV-1-infected children and 33 (7.6%) of 435 HIV-1-uninfected children with severe LRTI. The nutritional status and median ages of children from whom MTB was isolated from gastric washings did not differ by HIV status. A total of 52.8% of HIV-1-infected and 72.3% of HIV-1-uninfected children with culture-proven tuberculosis were of age- ). Of the 6 HIV-1-infected children from whom highly P p .38 penicillin-resistant (MIC, 2 mg/mL) S. pneumoniae were isolated, none died.
Discussion
Our results illustrate the detrimental effect that the HIV epidemic has had on reducing childhood morbidity and mortality related to LRTI in an area with a high prevalence of HIV-1 infection [6] . Although the prevalence of HIV-1 infection is !5% among children aged !5 years, children this age accounted for 45% of those hospitalized and 84.7% of those who died because of severe LRTI. In addition, the greater age of HIV-1-infected children in our study demonstrates their persistent risk of developing bacterial severe LRTI, owing to their impaired immune systems, compared with HIV-1-uninfected children [9, 16] . The longer duration of illness and greater CFR in both well-nourished and malnourished HIV-1-infected children may be related to PCP.
Limitations of our study are that we did not investigate for PCP and that we relied on clinical criteria coupled with HIV ELISA reactivity to diagnose HIV-1 infection in children aged !15 months who fulfilled clinical criteria of moderate or severe HIV-1 infection (table 2) . This is the standard method of diagnosing HIV-1 in children at the study site because of the high prevalence of HIV-1 infection and the high cost of performing HIV-1 PCR tests. Although this may have caused some children to be misclassified as HIV-1-infected, considering the associated spectrum of signs and symptoms present in these children, the number misclassified is probably low and unlikely to alter the conclusions of our study significantly.
Since lung aspirates are not routinely performed at our hospital, blood cultures are the only available method for identifying bacterial causes of LRTI in nonintubated children. Therefore, the calculated burden of disease in our study probably Table 5 . Antibiotic-resistance patterns of bacteria causing community-acquired severe acute lower respiratory tract infections in HIV-1-infected children (HIV-1 ϩ ) and HIV-1-uninfected children (HIV-1 Ϫ ). underestimates the true incidence of disease by 3-to 4-fold, since bacteremia probably occurred in only 10%-30% of children with bacterial pneumonia [17] , and ∼10% of children from the study area may have been hospitalized elsewhere.
In addition to the increased burden of bacterial LRTI. there were differences in the spectrum of bacteria and antibiotic susceptibility patterns in HIV-1-infected children with severe LRTI. Of the bacterial isolates from HIV-1-infected children, 12 (14.6%) of 82 were multiple-antibiotic resistant E. coli or MRSA. Although the emerging role of community-acquired MRSA has recently been described in children, there are no reports describing its importance in children with severe LRTI from an area with a high prevalence of HIV-1 infection [18] . Although pneumonia associated with intermediate penicillin resistance has not been associated with clinical failure in HIV-1-infected adults or uninfected children treated with penicillins [19, 20] , our study, like other studies, confirms the importance of HIV-1 infection as a risk factor for isolating antibiotic-resistant S. pneumoniae [21] .
The current antibiotics of choice for empirical treatment of children with severe LRTI at Chris Hani-Baragwanath Hospital is either ampicillin or cefuroxime. TMP-SMZ (20 mg TMP/kg/day plus 100 mg SMZ/kg/day) is added to the treatment schedule to treat for PCP in children suspected or known to be HIV-1-infected. As shown in table 4, in vitro susceptibility testing suggests this choice of antibiotic may be inadequate for HIV-1-infected children with severe LRTI due to antibioticresistant E. coli and S. aureus.
The finding that all the common pathogens that cause LRTI in HIV-1-infected children have a high level of resistance to TMP-SMZ supports the recommendations of a communitybased study in Pakistan that showed ampicillin to be superior to TMP-SMZ for managing severe LRTI [22] . Although chloramphenicol would have provided broader cover against the isolated bacteria, this would still not have been sufficient to cover for all MRSA and E. coli (table 4). Our data suggest that an aminoglycoside and vancomycin may need to be added, in addition to ampicillin-clavulanic acid or cefuroxime, for the management of children hospitalized with severe LRTI who are known or suspected to be infected with HIV-1 and who do not respond to initial empirical therapy. However, the costs and benefits of this strategy require further evaluation, as do its potential effects on further selection of antibiotic-resistant bacteria in these children.
Much of the emphasis of the World Health Organization program regarding LRTI has focused on early empirical antibiotic therapy for common bacterial causes of pneumonia in children aged !5 years [11] . Areas with high incidence of LRTI also tend to be areas where tuberculosis is endemic [23, 24] . Most studies on the etiology of severe acute LRTI in children have not investigated for concurrent MTB infection [2] . In 1994, the estimated incidence of tuberculosis in adults from the study area was 311/100,000 [25] , and 49% of children diagnosed as having pulmonary tuberculosis in this community were also HIV-1-infected [26] . Our finding that there is an increased estimated incidence risk that MTB will be isolated from HIV-1-infected children than from HIV-1-uninfected children may be biased, since HIV-1-infected children were investigated more often for tuberculosis.
However, based on the number of children from whom MTB was cultured in this study, ∼25% of children who present with severe LRTI may have had pulmonary tuberculosis (PTB), since gastric washings are positive in only 20%-50% of children with tuberculosis [27] . Although respiratory distress due to PTB is an uncommon presentation of primary PTB [28] , our data suggest that MTB is an important concurrent pathogen in both HIV-1-infected and HIV-1-uninfected children hospitalized with severe LRTI. On the basis of our data, it is not possible to determine whether HIV-1-infected children are more susceptible to acute symptomatic tuberculous pneumonia than HIV-1-uninfected children. Many of the children diagnosed with tuberculosis who presented with severe LRTI may have had concurrent bacterial pneumonia, as indicated in our study by the 10% of children with culture proven tuberculosis and concurrent bacteremia. The finding of concurrent bacteremia in children with tuberculosis who present with severe LRTI is important, because many of these children may initially respond clinically to antimicrobial therapy and may be discharged with undiagnosed underlying tuberculosis. This factor might also limit the success of the WHO program on the management of severe LRTI [11] in reducing mortality especially in areas where tuberculosis is endemic.
Conclusion
The HIV epidemic reversed any benefits that may have been derived from improved primary health care in our study area. The management of community-acquired bacterial severe LRTI requires knowledge of the expanded spectrum of antibioticresistant organisms that are causing diseases in areas with a high prevalence of HIV-1 infection. Furthermore, the high rate of isolation of MTB in children admitted for acute severe LRTI emphasizes the need for an integration of programs aimed at managing tuberculosis and LRTI in areas with a high incidence of both these illnesses.
